Core Scientific $CORZ has priced an upsized offering of $550 million convertible senior notes due 2031, increased from the previously announced $500 million. The zero-interest notes will mature on June 15, 2031, with an initial conversion rate of 44.4587 shares per $1,000 principal amount, representing a conversion price of approximately $22.49 per share. The company granted initial purchasers an option to buy an additional $75 million in notes. The net proceeds, estimated at $535.6 million (or $608.7 million if the option is exercised), will be used for general corporate purposes including working capital, operating expenses, and capital expenditures.
#CORZ